HGI has been criticized because (1) as big science
with top down administration it seems to squeeze out local initiative
by smaller laboratories and (2) the large financial investment
in genome mapping and sequencing leaves little funds left over
for other worthy research projects. "The genome project has
been overhyped and oversold," complains Boston University
School of Medicine health law professor George J. Annas, who then
adds, "it is the obligation of those who take legal and ethical
issues seriously to insure that the dangers, as well as the opportunities,
are rigorously and publicly explored." Whos Afraid
of the Human Genome? Hastings Center Report, 19:4
(July-August, 1989) 21.
To return to the previous topic,
click on your browser's 'Back' button.